Essure is the world’s only non-surgical and permanent form of birth control, manufactured by Bayer. The device is at the center of several class-action lawsuits from women who have experienced excruciating pain and other symptoms after having the device implanted. Reveal News reports that the company has now pulled the contraceptive device from all markets worldwide except the United States, where it still remains available.
Though Bayer has pulled Essure from every market aside from the United Stated, the U.S. Food and Drug Administration will continue to monitor the device’s safety and efficacy.
Increased scrutiny in Brazil, Australia, and the European Union led to the manufacturer’s decision. Australia’s Department of Health issued a hazard warning and pulled the device from shelves on August 30th.
Patients who have had the device implanted have reported changes to their menstrual cycle, unintended pregnancies, device migration, and the perforation of female organs. Some of these complications require the removal of the device, which requires invasive abdominal surgery.
Bayer maintains that the removal of the device from foreign markets had nothing to do with the safety of the device. They also stand behind Essure as a safe and reliable means of nonsurgical permanent birth control.
The Food and Drug Administration states on its own website that the agency believes the benefits outweigh the risks, but required Bayer update the label to ensure that women are aware of the risks. They also required additional long-term studies on the device, whose results are due in 2023.
Have you experienced complications as a result of the implantation of an Essure device? Let the attorney at the law offices of John Foy & Associates fight to get you the compensation you deserve. Call us today.